Aclaris Therapeutics | 4:持股變動聲明-高管 Walker Neal
05/03 16:26 (美東)
Aclaris Therapeutics | ARS:年度報告
04/25 07:05 (美東)
Aclaris Therapeutics | DEFA14A:其他
04/25 07:05 (美東)
Aclaris Therapeutics | DEF 14A:股東委託書決議
04/25 07:05 (美東)
Aclaris Therapeutics | 4:持股變動聲明-高管 Walker Neal
04/03 17:05 (美東)
Aclaris Therapeutics | 8-K:重大事件
03/19 16:33 (美東)
Aclaris Therapeutics | 4:持股變動聲明-高管 Balthaser Kevin
03/05 17:13 (美東)
Aclaris Therapeutics | 4:持股變動聲明-高管 Monahan Joseph
03/05 17:12 (美東)
Aclaris Therapeutics | 4:持股變動聲明-高管 Walker Neal
03/05 17:09 (美東)
Aclaris Therapeutics | 4:持股變動聲明-董事 Powell Andrew Kenneth William
03/05 17:05 (美東)
Aclaris Therapeutics | 10-K:年度報表
02/27 07:35 (美東)
Aclaris Therapeutics | 8-K:Aclaris Therapeutics公佈2023年第四季度和全年財務業績,並提供公司最新情況
02/27 07:20 (美東)
Aclaris Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-Venrock Healthcare Capital Partners II, L.P.(0.0%),VHCP Co-Investment Holdings II, LLC(0.0%)等
02/14 20:33 (美東)
Aclaris Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-RA Capital Management, L.P.(0%),Peter Kolchinsky(0%)等
02/14 17:30 (美東)
Aclaris Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-Kenneth Griffin(7.6%),Citadel Advisors LLC(6.1%)等
02/14 17:05 (美東)
Aclaris Therapeutics | SC 13G:超過5%持股股東披露文件-Millennium Management LLC(5.3%),Millennium Group Management LLC(5.3%)等
02/14 16:22 (美東)
Aclaris Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-TANG CAPITAL PARTNERS, LP(2.5%),Tang Capital Management, LLC(2.5%)等
02/14 16:03 (美東)
Aclaris Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-Rock Springs Capital Management LP(4.23%),Rock Springs Capital LLC(4.23%)等
02/14 15:51 (美東)
Aclaris Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-Biotechnology Value Fund, L.P.(0%),BVF I GP LLC(0%)等
02/14 10:32 (美東)
Aclaris Therapeutics | SC 13G:超過5%持股股東披露文件-The Vanguard Group(6.67%)
02/13 18:18 (美東)
暫無數據
暫無數據